A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so ...

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

McKesson Corporation's ( NYSE:MCK ) stock was strong despite it releasing a soft earnings report last week. Our... The city ...

The pharmaceutical distributor has launched InspiroGene, a business unit offering logistics and other support for ...

McKesson (MCK) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

McKesson (MCK) and Cencora (COR) ordered by a jury in Baltimore to pay $266M in damages to the city for their role in causing ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...

The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

McKesson (MCK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...